Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» TRILOGY At ESC: No Advantage For Prasugrel Over Clopidogrel In Medical ACS Patients
TRILOGY At ESC: No Advantage For Prasugrel Over Clopidogrel In Medical ACS Patients
TRILOGY At ESC: No Advantage For Prasugrel Over Clopidogrel In Medical ACS Patients
Submitted by
admin
on August 26, 2012 - 11:01am
Source:
Forbes
News Tags:
Sanofi
Prasugrel
Plavix
Effient
Daiichi Sankyo
Clopidogrel
antiplatelet therapy
Eli Lilly
Headline:
TRILOGY At ESC: No Advantage For Prasugrel Over Clopidogrel In Medical ACS Patients
Do Not Allow Advertisers to Use My Personal information
